V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220004510 | 220010906 | 1.65 | 74 | null | 2017-01-25 | 2017-01-26 | Cytarabine Low Dose | Y | N | 220026194 | CYTARABINE |
| 220004511 | 220010906 | 1.57 | 110.9 | Disease modification (D) | 2014-10-28 | 2014-10-28 | CYTARABINE | N | N | 220026194 | CYTARABINE |
| 220004512 | 220001801 | null | 65 | Palliative (P) | 2017-09-24 | 2017-09-24 | Cytarabine Low Dose | N | N | 220026196 | CYTARABINE |
| 220004513 | 220001801 | 1.6 | null | Curative (C) | 2013-04-02 | 2013-04-02 | LI-1 TRIAL | 01 | null | 220026196 | TRIAL |
| 220004514 | 220001801 | 0 | null | Palliative (P) | null | 2016-09-18 | Cytarabine Low Dose | N | N | 220026196 | CYTARABINE |
| 220004515 | 220001801 | 0 | null | null | 2013-12-06 | 2013-12-24 | AML17 TRIAL | 1 | N | 220026196 | AML17 TRIAL |
| 220004516 | 220001801 | null | 68.8 | Curative (C) | 2017-07-11 | 2017-07-11 | AML17 TRIAL | N | N | 220026196 | AML17 TRIAL |
| 220004517 | 220021195 | 1.85 | 75.6 | Disease modification (D) | null | 2016-07-29 | Trial Unspecified | null | null | 220026212 | TRIAL |
| 220004518 | 220021195 | 1.6 | 71 | Curative (C) | 2015-03-14 | 2015-03-14 | AML17 TRIAL | N | N | 220026212 | AML17 TRIAL |
| 220004519 | 220021195 | 1.73 | null | Curative (C) | 2013-09-17 | 2013-09-17 | AML17 TRIAL | 1 | null | 220026212 | AML17 TRIAL |
| 220004520 | 220021195 | 1.59 | null | Palliative (P) | 2016-05-22 | 2016-05-24 | CYTARABINE | N | null | 220026212 | CYTARABINE |
| 220004521 | 220021195 | 1.58 | 58.6 | Palliative (P) | 2015-03-01 | 2015-03-01 | Trial Unspecified | Y | N | 220026212 | TRIAL |
| 220004522 | 220001802 | 1.79 | 48.8 | Palliative (P) | 2013-02-19 | 2013-02-21 | Cytarabine Low Dose | 02 | N | 220026227 | CYTARABINE |
| 220004523 | 220001802 | null | null | Palliative (P) | 2013-02-17 | 2013-04-05 | CYTARABINE | N | N | 220026227 | CYTARABINE |
| 220004524 | 220001802 | 1.59 | 72.9 | Palliative (P) | 2013-02-27 | 2013-03-01 | Cytarabine Low Dose | 02 | N | 220026227 | CYTARABINE |
| 220004525 | 220001802 | 1.74 | 68 | Disease modification (D) | 2015-12-19 | 2015-12-28 | Cytarabine low (10to20mg/m2) IV/SC | N | N | 220026227 | CYTARABINE |
| 220004526 | 220001802 | 1.6 | 89.6 | Curative (C) | 2014-02-10 | 2014-02-10 | Trial Unspecified | 01 | Y | 220026227 | TRIAL |
| 220004527 | 220001802 | 0 | null | Palliative (P) | 2016-12-31 | 2017-01-01 | Trial Unspecified | 01 | N | 220026227 | TRIAL |
| 220004528 | 220001802 | 1.55 | 73.7 | Curative (C) | 2017-11-04 | 2017-11-08 | Trial Unspecified | Y | N | 220026227 | TRIAL |
| 220004529 | 220001802 | 1.48 | 77.4 | Palliative (P) | 2018-01-13 | 2018-01-28 | Trial Unspecified | Y | N | 220026227 | TRIAL |
| 220004530 | 220022148 | 1.63 | 82.3 | null | 2013-07-19 | 2013-07-19 | AML17 TRIAL | N | Y | 220026248 | AML17 TRIAL |
| 220004531 | 220001803 | null | 84.6 | Curative (C) | 2015-03-18 | 2015-03-22 | AML17 TRIAL | Y | N | 220026249 | AML17 TRIAL |
| 220004532 | 220001803 | 1.65 | 95.5 | Curative (C) | 2013-04-05 | 2013-04-06 | Trial Unspecified | 01 | N | 220026249 | TRIAL |
| 220004533 | 220001803 | 1.58 | 92.499 | Curative (C) | 2014-01-18 | 2014-01-20 | AML17 TRIAL | Y | null | 220026249 | AML17 TRIAL |
| 220004534 | 220001803 | 1.57 | 79.4 | Not known (9) | 2017-11-25 | 2017-11-30 | AML17 TRIAL | N | null | 220026249 | AML17 TRIAL |
| 220004535 | 220001804 | 0 | null | Not known (9) | 2014-05-22 | 2014-05-22 | AML17 TRIAL | null | N | 220026257 | AML17 TRIAL |
| 220004536 | 220001805 | null | 105.3 | Curative (C) | 2017-02-12 | 2017-02-12 | Trial Unspecified | Y | N | 220026258 | TRIAL |
| 220004537 | 220001805 | 1.57 | 93 | Curative (C) | 2016-09-05 | 2016-09-05 | AML17 TRIAL | 01 | N | 220026258 | AML17 TRIAL |
| 220004538 | 220001805 | 1.85 | null | Curative (C) | 2018-03-06 | 2018-03-06 | Cytarabine Low Dose | 2 | N | 220026258 | CYTARABINE |
| 220004539 | 220001806 | 1.75 | null | Palliative (P) | 2014-09-17 | 2014-09-21 | Cytarabine Low Dose | N | N | 220026263 | CYTARABINE |
| 220004540 | 220001806 | 1.63 | 65 | Curative (C) | 2017-06-14 | 2017-06-14 | AML17 TRIAL | 01 | N | 220026263 | AML17 TRIAL |
| 220004541 | 220001807 | 1.86 | 85 | Disease modification (D) | 2013-02-14 | 2013-02-24 | Cytarabine Low Dose | 2 | null | 220026266 | CYTARABINE |
| 220004542 | 220001808 | 1.65 | null | Curative (C) | 2013-03-06 | 2013-03-06 | AML17 TRIAL | 01 | N | 220026267 | AML17 TRIAL |
| 220004543 | 220001808 | 1.64 | null | Palliative (P) | 2017-10-26 | 2017-10-26 | CYTARABINE | N | N | 220026267 | CYTARABINE |
| 220004544 | 220001808 | 1.77 | 83.5 | Curative (C) | 2016-09-27 | 2016-09-28 | Trial Unspecified | 01 | null | 220026267 | TRIAL |
| 220004545 | 220018671 | 1.62 | null | Palliative (P) | 2013-06-08 | 2013-06-08 | AML17 TRIAL | null | N | 220026273 | AML17 TRIAL |
| 220004546 | 220001809 | null | 90 | Disease modification (D) | 2013-04-16 | 2013-04-16 | Cytarabine low (10to20mg/m2) IV/SC | N | N | 220026275 | CYTARABINE |
| 220004547 | 220001809 | null | null | Adjuvant (A) | 2015-12-18 | 2015-12-20 | Cytarabine Low Dose | N | N | 220026275 | CYTARABINE |
| 220004548 | 220001810 | 1.63 | 68 | null | 2016-04-16 | 2016-04-16 | AML17 TRIAL | N | N | 220026282 | AML17 TRIAL |
| 220004549 | 220001810 | 1.59 | null | Disease modification (D) | 2018-01-09 | 2018-01-17 | Cytarabine Low Dose | N | N | 220026282 | CYTARABINE |
| 220004550 | 220001810 | 1.65 | 100.9 | null | 2017-12-18 | 2017-12-19 | Trial Unspecified | 1 | N | 220026282 | TRIAL |
| 220004551 | 220001811 | 1.68 | 99 | Curative (C) | 2015-09-23 | 2015-09-23 | AML17 TRIAL | 02 | N | 220026288 | AML17 TRIAL |
| 220004552 | 220001812 | 1.8 | 110 | Not known (9) | 2013-01-18 | 2013-01-18 | Trial Unspecified | Y | N | 220026289 | TRIAL |
| 220004556 | 220001813 | null | null | Disease modification (D) | 2015-09-19 | 2015-09-22 | CYTARABINE | N | N | 220026294 | CYTARABINE |
| 220004557 | 220001813 | null | 83.6 | Curative (C) | 2013-04-02 | 2013-04-02 | AML17 TRIAL | 1 | N | 220026294 | AML17 TRIAL |
| 220004558 | 220001813 | 1.73 | null | Curative (C) | 2013-09-07 | 2013-09-19 | Trial Unspecified | Y | N | 220026294 | TRIAL |
| 220004559 | 220001813 | 1.7 | null | Palliative (P) | 2017-04-04 | 2017-04-04 | CYTARABINE | N | N | 220026294 | CYTARABINE |
| 220004560 | 220001813 | 1.6 | 82 | Curative (C) | 2017-06-26 | 2017-06-29 | Trial Unspecified | Y | N | 220026294 | TRIAL |
| 220004561 | 220001814 | null | 58 | Palliative (P) | 2015-04-08 | 2015-04-12 | CYTARABINE | 02 | N | 220026308 | CYTARABINE |
| 220004562 | 220010917 | null | 81.9 | Curative (C) | 2015-04-20 | 2015-04-20 | AML17 TRIAL | Y | null | 220026309 | AML17 TRIAL |